Jessica Matthews raises awareness of deadly cancer outcomes for Black people while sharing intimate moments, losing her hair ...

Rice University chemist and director of the university’s Synthesis X Center Han Xiao and cancer biologist Dihua Yu of The ...

A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) has announced the resumption of patient enrollment in a Phase 1/2 clinical trial evaluating seclidemstat combined with azacitidine for myelodysplastic ...

ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving ...

HOUSTON and SALT LAKE CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center and ... Genetics and the clinical and translational research expertise of MD ...

Being evaluated for the treatment of metastatic colorectal cancer, the combination regimen achieved an objective response ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

The Mayo Clinic provides a perspective on 7 ways that individuals can reduce their risk: Eat healthier foods (thereby also ...

Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ ...